MAIA Biotechnology, Inc. Income Tax Expense
MAIA Biotechnology, Inc. (MAIA) reported Income Tax Expense of $339 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-05-11
- MAIA Biotechnology, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $339.00.
- MAIA Biotechnology, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $2.00K, a 0.00% change year-over-year.
- MAIA Biotechnology, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- MAIA Biotechnology, Inc. income tax expense (benefit) for the quarter ending 2025-06-30 was $0.00.
- MAIA Biotechnology, Inc. income tax expense (benefit) for fiscal 2025 was $2.00K, a 0.00% change from fiscal 2024.
- MAIA Biotechnology, Inc. income tax expense (benefit) for fiscal 2024 was $2.00K.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-03-31 | $339.00 10-Q · filed 2026-05-11 | $2.34K derived: sum of 2 quarters · filed 2026-05-11 | $2.34K derived: sum of 3 quarters · filed 2026-05-11 | $2.34K derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $2.00K derived: sum of 2 quarters · filed 2026-03-23 | $2.00K derived: sum of 3 quarters · filed 2026-03-23 | $2.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | $2.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | $2.00K derived: sum of 3 quarters · filed 2026-05-11 | $2.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | $2.00K derived: sum of 2 quarters · filed 2026-05-11 | $2.00K derived: sum of 3 quarters · filed 2026-05-11 | $2.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $2.00K derived: sum of 2 quarters · filed 2026-03-23 | $2.00K derived: sum of 3 quarters · filed 2026-03-23 | $2.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-08 | |||
| 2021-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-02-06 | $0.00 10-Q/A · filed 2023-02-06 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |